+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of deslorelin acetate implants in horses: single implants in stallions and steroid-treated geldings and multiple implants in mares

Effects of deslorelin acetate implants in horses: single implants in stallions and steroid-treated geldings and multiple implants in mares

Journal of Animal Science 81(5): 1300-1307

Three experiments were performed to test the following hypotheses: 1) stallions and/or progesterone-estradiol-treated geldings could serve as models for the effects of a single implant of the GnRH analog, deslorelin acetate, on LH and FSH secretion by mares; and 2) multiple implants of deslorelin acetate could be used as a means of inducing ovarian atrophy in mares for future study of the mechanisms involved in the atrophy observed in some mares after a single implant. In Exp. 1, nine light horse stallions received either a single deslorelin implant (n = 5) or a sham injection (n = 4) on d 0. In Exp. 2, 12 geldings received daily injections of progesterone on d -20 through -4, followed by twice-daily injections of estradiol on d -2 to 0. On the morning of d 0, geldings received either a single deslorelin implant (n = 6) or a sham injection (n = 6). Daily injections of progesterone were resumed on d 2 through 15. In Exp. 1, plasma LH and FSH were elevated (P < 0.05) in the treatment group relative to controls at 4, 8, and 12 h after implant insertion. In the treated stallions, FSH was decreased (P < 0.05) on d 3 to 13, and LH was decreased on d 6 to 13. In Exp. 2, plasma LH and FSH were elevated (P < 0.05) at 4, 8, and 12 h after deslorelin implant insertion. Plasma LH was suppressed (P < 0.05) below controls on d 2 to 7, 9, and 11 to 15; plasma FSH was suppressed (P < 0.05) on d 4 to 15. In Exp. 3, 21 mares were used to determine whether multiple doses of deslorelin would cause ovarian atrophy. Mares received one of three treatments: 1) sham injections; 2) three implants on the first day; or 3) one implant per day for 3 d (n = 7 per group). Treatment with multiple implants increased (P < 0.05) the interovulatory interval by 14.8 d and suppressed (P < 0.01) LH and FSH concentrations for approximately 25 d; no mare exhibited ovarian atrophy. In conclusion, after an initial short-term increase in LH and FSH secretion, deslorelin implants caused long-term suppression of both gonadotropins in stallions as well as in geldings treated with progesterone and estradiol to mimic the estrous cycle. It is likely that either of these models may be useful for further study of this suppression in horses. Although multiple implants in mares suppressed gonadotropin secretion longer than a single implant, the lack of ovarian atrophy indicates that the atrophy observed after a single implant in previous experiments was likely due to the susceptibility of individual mares. Reprinted by permission of the publisher.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 009831248

Download citation: RISBibTeXText

PMID: 12772858

Related references

Effects of deslorelin acetate implants in horses: Single implants in stallions and steroid-treated geldings and multiple implants in mares1. Journal of Animal Science 81(5): 1300-1307, 2003

Effects of multiple GnRH analogue (deslorelin acetate) implants on cyclic mares. Theriogenology 58(2/4): 469-471, 2002

The failure rate of single tooth implants replacing failed implants may be greater than the failure rate of implants placed in sites previously not treated with implants. Journal of Evidence-Based Dental Practice 9(1): 32-33, 2009

Effects of implants containing the GnRH agonist deslorelin on testosterone release and semen characteristics in Shetland stallions. Animal Reproduction Science 2018, 2018

Long-term contraception by steroid-releasing implants. IV. Biological effectiveness of norethindrone acetate (ENTA) implants in rats and rabbits. Contraception 12(5): 549-568, 1975

Long-term contraception by steroid releasing implants. III. Mode of action of megestrol acetate (MA) administered by subcutaneous silastic implants in women. Indian Journal of Medical Research 63(11): 1620-1628, 1975

Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 2. Maintenance of ovarian function in patients with megestrol acetate implants. Acta Endocrinologica 73(2): 347-359, 1973

Interovulatory intervals in mares receiving deslorelin implants in Ireland (2009 to 2010). Veterinary Record 170(21): 541, 2012

Contraceptive effect and potential side-effects of deslorelin acetate implants in rats (Rattus norvegicus): preliminary observations. Canadian Journal of Veterinary Research 76(3): 209-214, 2013

Use of deslorelin short-term implants to induce ovulation in cycling mares during three consecutive estrous cycles. Animal Reproduction Science 39(2): 129-140, 1995

Evaluation of the efficacy and safety of single administration of 4.7-mg deslorelin acetate implants on egg production and plasma sex hormones in Japanese quail (Coturnix coturnix japonica). American Journal of Veterinary Research 74(2): 316-323, 2013

Assessing the Efficacy of Deslorelin Acetate Implants (Suprelorin) in Alternative Placement Sites. Journal of Zoo and Wildlife Medicine 49(1): 1-8, 2018

Location and removal of deslorelin acetate implants in female African lions (Panthera leo). Journal of Zoo and Wildlife Medicine 45(2): 397-401, 2014

Study of two types of dental implants for immediate loading (expansion implants and locking pin implants) in the Beagle dog. Morphologie 88(282): 149-154, 2005

Clinical evaluation of dental implants with surfaces roughened by anodic oxidation, dual acid-etched implants, and machined implants. International Journal of Oral and Maxillofacial Implants 20(5): 793-798, 2005